Author

Norio Yamamoto

Kanazawa UniversityORCID 0000-0002-7250-625XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Byung Mo KangiD· 1 shared Hiroaki KimuraiD· 1 shared Hiroyuki Tsuchiya· 1 shared Katsuhiro HayashiiD· 1 shared Kentaro IgarashiiD· 1 shared KOHEI MIZUTA· 1 shared Michael BouvetiD· 1 shared Qinghong Han· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Byung Mo KangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyFrontiers in OncologyPeer-reviewedDec 8, 2025

Human fibrosarcoma cells selected for very-high doxorubicin resistance, acquire trabectedin and eribulin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression

Sei Morinaga, Qinghong Han, KOHEI MIZUTA…·Robert M. Hoffman

This study shows that doxorubicin-resistant fibrosarcoma cells are cross-resistant to trabectedin and eribulin but remain sensitive to recombinant methioninase, with increased c-MYC expression.

1 citation

humanexperimental assay

𝕏 PostBluesky